Marco Caremi
Chief Executive Officer bei Newron Sweden AB
Profil
Marco Caremi is currently working as a Director at Hunter-Fleming Ltd., President & Director at Newron Pharmaceuticals US, Inc., and Co-General Manager at Newron Sweden AB.
Previously, he worked as a Director-Business Development at Schwarz Pharma SpA from 1998 to 2002, Sales Representative & Sales Specialist at Polifarma SpA, Manager-Business Development at Schering-Plough SpA from 1996 to 1998, and Executive Vice President-Business Development at Newron Pharmaceuticals SpA from 2002 to 2023.
He completed his undergraduate degree from the University of Milan.
Aktive Positionen von Marco Caremi
| Unternehmen | Position | Beginn |
|---|---|---|
Hunter-Fleming Ltd.
 Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Director/Board Member | - |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
| Newron Pharmaceuticals US, Inc. | President | - |
Ehemalige bekannte Positionen von Marco Caremi
| Unternehmen | Position | Ende |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | General Counsel | 01.01.2012 |
| Schwarz Pharma SpA | Corporate Officer/Principal | 01.01.2002 |
| Schering-Plough SpA | Corporate Officer/Principal | 01.01.1998 |
Polifarma SpA
 Polifarma SpA Drugstore ChainsRetail Trade Polifarma SpA engages in the manufacture of ethical medicines. It specializes in the provision of pharmaceutical preparations for cardiovascular, gastroenterology, central nervous system, infectious diseases, and pain and inflammation areas. The company was founded in 1919 and is headquartered in Rome, Italy. | Sales & Marketing | - |
Ausbildung von Marco Caremi
| University of Milan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Hunter-Fleming Ltd.
Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Health Technology |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Polifarma SpA
Polifarma SpA Drugstore ChainsRetail Trade Polifarma SpA engages in the manufacture of ethical medicines. It specializes in the provision of pharmaceutical preparations for cardiovascular, gastroenterology, central nervous system, infectious diseases, and pain and inflammation areas. The company was founded in 1919 and is headquartered in Rome, Italy. | Retail Trade |
| Newron Pharmaceuticals US, Inc. | |
| Schering-Plough SpA | |
| Schwarz Pharma SpA |
